BusinessNew Publication Summarizes Phase 1 Studies of CK-2127107 Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve ActivationBy Nasdaq OMXNov 30, 2017, 12:30 PM UTC
BusinessArzeda Officially Closes Series A with Total $15.2 Million to Revolutionize Chemical Production with Protein DesignBy Nasdaq OMXNov 28, 2017, 7:33 PM UTC
BusinessDeciphera Pharmaceuticals, Inc. Announces Orphan Drug Designation from the EMA for DCC-2618 for the Treatment of Gastrointestinal Stromal TumorsBy Nasdaq OMXNov 28, 2017, 12:00 PM UTC
BusinessAxsome Therapeutics Announces AXS-07 for the Treatment of MigraineBy Nasdaq OMXNov 28, 2017, 12:00 PM UTC
BusinessNewLink Genetics to Participate in Upcoming Investor ConferenceBy Nasdaq OMXNov 27, 2017, 2:24 PM UTC
BusinessCrown Bioscience and Data Sciences International (DSI) Partner to Advance Metabolic Disease Research Using an Implanted Telemetry Device for Long-Term Blood Glucose MonitoringBy Nasdaq OMXNov 23, 2017, 1:00 PM UTC
BusinessSoleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare ConferenceBy Nasdaq OMXNov 22, 2017, 1:00 PM UTC
